METHOD OF OBTAINING CONTINUOUS CELL LINE AND APPLICATION OF CONTINUOUS CELL LINE Russian patent published in 2008 - IPC A61K39/255 C12N7/00 C12N5/14 

Abstract RU 2329060 C2

FIELD: biotechnologies.

SUBSTANCE: method of obtaining a continuous cell line capable of maintaining growth of cell-associated alpha herpes viruses involves the infection or transfection of a cell with the nucleic acid or fragment of the herpes virus, the selection of cells expressing the said nucleic acid or its fragment, and the cultivation of the said infected or transfected cell or its progeny in conditions suitable for the expression of the said nucleic acid and the multiplication of the said cell or its progeny. The said nucleic acid includes the herpes virus glycoprotein gene gE or its functional fragment. The expression of the said gE gene or its functional fragment takes place in a sustainable manner. The cell of the continuous cell line capable of maintaining growth of cell-associated alpha herpes viruses includes the herpes virus nucleic acid or its fragment. The said nucleic acid includes the herpes virus glycoprotein gene gE or its functional fragment, the expression of the said gE gene or its functional fragment takes place in a sustainable manner. The said cell can go through at least 10 passages. The invention group includes the application of the said cell for obtaining a vaccine capable of inducing protection against disease in vertebrates, and for obtaining and/or maintaining and/or isolation of a hypervirulent and/or very virulent Marek's disease virus strain, as well as for obtaining the Marek's disease diagnostic antigen. The invention group also includes a method of obtaining and/or isolation and/or maintaining the Marek's disease virus strain. The method involves the infection of the above cell with the said strain and the cultivation of the said cell in conditions suitable for the multiplication of the said cell and obtaining, maintaining, and isolation of the Marek's disease virus.

EFFECT: invention group provides a method of obtaining a vaccine capable of inducing protection against the disease; allows to satisfy the need in new cell systems allowing to maintain new properties acquired by the cell.

35 cl, 6 dwg, 6 ex.

Similar patents RU2329060C2

Title Year Author Number
IMPROVED DILUENT FOR VACCINE AGAINST CELL-ASSOCIATED ALPHA-HERPESVIRUS 2018
  • De Groof, Ad
  • Verstegen, Iwan
RU2774588C2
RECOMBINANT MAREK'S DISEASE VIRUSES AND USES THEREOF 2014
  • Esaki Motoyuki
  • Saito Sudzi
  • Sato Takanori
RU2681889C2
RECOMBINANT NONPATHOGENIC MDV VECTOR PROVIDING POLY-SPECIFIC IMMUNITY 2012
  • Sondermejer Paulus Yakobus Antonius
  • Verstegen Ivan
RU2593950C2
RECOMBINANT HVT VECTORS EXPRESSING BIRD PATHOGENS ANTIGENS AND THEIR APPLICATION 2012
  • Byublo Mishel
  • Mebatson Tezom
  • Pritchard Dzhojs
  • Lints Perri
RU2620936C2
PRODUCING POULTRY AND OTHER ANIMALS RESISTANT TO VIRAL DISEASES 2006
  • Kakhana Ronen
RU2533804C2
RECOMBINANT NON-PATHOGENIC STRUCTURES OF MAREK'S DISEASE VIRUS, ENCODING ANTIGENS OF INFECTIOUS LARYNGOTRACHEITIS VIRUS AND INFECTIOUS BURSITIS VIRUS 2017
  • Cook, Stephanie
  • Morsey, Mohamad
  • Tarpey, Ian
  • Verstegen, Iwan
  • Sondermeijer, Paulus, Jacobus, Antonius
  • Vermeij, Paul
RU2777400C2
CONSTRUCTS OF RECOMBINANT NONPATHOGENIC MAREK'S DISEASE VIRUS CODING ANTIGENS OF INFECTIOUS LARYNGOTRACHEITIS VIRUS AND NEWCASTLE DISEASE VIRUS 2012
  • Kuk Stefani
  • Morsi Mokhamad
  • Petersen Geri
  • Sondermejer Paulus Yakobus Antonius
RU2624037C2
METHOD FOR PREPARING VIRUS-VACCINE AGAINST MARECK'S DISEASE 2001
  • Kuljashbekova Sh.K.
  • Gusev A.A.
  • Smolenskij V.I.
  • Barros-Paloma E.V.
  • Kurnenkova E.V.
  • Starov S.K.
RU2209635C2
RECOMBINANT VIRUSES MDV1 AND APPLICATION THEREOF 2016
  • Ishihara Yukari
  • Esaki Motoyuki
  • Saitoh Shuji
RU2714423C2
IMMORTALIZED CHICKEN EMBRYO FIBROBLASTS 2015
  • Kool, Jaap
RU2694318C2

RU 2 329 060 C2

Authors

Osterrider Nikolaus

Shumakher Dehniel

Dates

2008-07-20Published

2003-02-05Filed